Executive Summary
Tristel plc is a healthcare business specialising in infection control in hospitals. Tristel markets a proprietary chlorine dioxide chemistry that is highly effective in destroying all types of bacteria (including bacterial spores, tuberculosis and MRSA), fungi and viruses and is one of a small group of sporicidal agents that is safe and easy to use. Tristel's core product range of instrument disinfectants has become the market leader in the UK Acute & Private Hospital sector. They are used to decontaminate heat sensitive endoscopic and ultrasound instruments in over 375 hospitals, representing some 60 per cent. of all UK NHS Acute & Private Hospitals.
Company History
Current Events
Business Model
Products/Services
Segments/Customers
Production/Operations
Distribution/Routes to Market
Market & Competition
Market Share
Main Competitors
Competitive Strengths and Weaknesses
Management
Financials
Profit & Loss
Balance sheet
Cashflow
Valuation
Comparable Companies
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats
